BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35327650)

  • 21. Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of
    Bullich S; Barret O; Constantinescu C; Sandiego C; Mueller A; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Madonia J; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
    J Nucl Med; 2020 Jun; 61(6):920-927. PubMed ID: 31712324
    [No Abstract]   [Full Text] [Related]  

  • 22. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.
    Oh M; Oh SJ; Lee SJ; Oh JS; Roh JH; Chung SJ; Lee JH; Lee CS; Kim JS
    Clin Nucl Med; 2020 Nov; 45(11):841-847. PubMed ID: 32910050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau PET imaging with
    Mueller A; Bullich S; Barret O; Madonia J; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
    J Nucl Med; 2020 Jun; 61(6):911-919. PubMed ID: 31712323
    [No Abstract]   [Full Text] [Related]  

  • 25. Phosphorylation of different tau sites during progression of Alzheimer's disease.
    Neddens J; Temmel M; Flunkert S; Kerschbaumer B; Hoeller C; Loeffler T; Niederkofler V; Daum G; Attems J; Hutter-Paier B
    Acta Neuropathol Commun; 2018 Jun; 6(1):52. PubMed ID: 29958544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
    Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
    Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of [
    Schmidt ME; Janssens L; Moechars D; Rombouts FJR; Timmers M; Barret O; Constantinescu CC; Madonia J; Russell DS; Sandiego CM; Kolb H
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3176-3185. PubMed ID: 32535652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals.
    Biel D; Brendel M; Rubinski A; Buerger K; Janowitz D; Dichgans M; Franzmeier N;
    Alzheimers Res Ther; 2021 Aug; 13(1):137. PubMed ID: 34384484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study.
    Wharton SB; Minett T; Drew D; Forster G; Matthews F; Brayne C; Ince PG;
    Acta Neuropathol Commun; 2016 Feb; 4():11. PubMed ID: 26857919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
    Koychev I; Hofer M; Friedman N
    J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo quantification of neurofibrillary tangles with [
    Pascoal TA; Shin M; Kang MS; Chamoun M; Chartrand D; Mathotaarachchi S; Bennacef I; Therriault J; Ng KP; Hopewell R; Bouhachi R; Hsiao HH; Benedet AL; Soucy JP; Massarweh G; Gauthier S; Rosa-Neto P
    Alzheimers Res Ther; 2018 Jul; 10(1):74. PubMed ID: 30064520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study.
    Thom M; Liu JY; Thompson P; Phadke R; Narkiewicz M; Martinian L; Marsdon D; Koepp M; Caboclo L; Catarino CB; Sisodiya SM
    Brain; 2011 Oct; 134(Pt 10):2969-81. PubMed ID: 21903728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical Evaluation of
    Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
    J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging.
    Macedo AC; Therriault J; Tissot C; Fernandez-Arias J; Ferreira PCL; Vitali P; Servaes S; Rahmouni N; Vermeiren M; Bezgin G; Lussier FZ; Stevenson J; Wang YT; Socualaya KQ; Kunach P; Nazneen T; Hosseini SA; Pallen V; Stevenson A; Ferrari-Souza JP; Bellaver B; Leffa DT; Ng KP; Zimmer ER; Pascoal TA; Gauthier S; Rosa-Neto P
    Brain Commun; 2024; 6(2):fcae043. PubMed ID: 38482373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head-to-head comparison of [
    Aguero C; Dhaynaut M; Amaral AC; Moon SH; Neelamegam R; Scapellato M; Carazo-Casas C; Kumar S; El Fakhri G; Johnson K; Frosch MP; Normandin MD; Gómez-Isla T
    Acta Neuropathol; 2024 Jan; 147(1):25. PubMed ID: 38280071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with
    Lohith TG; Bennacef I; Vandenberghe R; Vandenbulcke M; Salinas CA; Declercq R; Reynders T; Telan-Choing NF; Riffel K; Celen S; Serdons K; Bormans G; Tsai K; Walji A; Hostetler ED; Evelhoch JL; Van Laere K; Forman M; Stoch A; Sur C; Struyk A
    J Nucl Med; 2019 Jan; 60(1):107-114. PubMed ID: 29880509
    [No Abstract]   [Full Text] [Related]  

  • 37. Argyrophilic grain pathology as a natural model of tau propagation.
    Rábano A; Rodal I; Cuadros R; Calero M; Hernández F; Ávila J
    J Alzheimers Dis; 2014; 40 Suppl 1():S123-33. PubMed ID: 24577470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
    Merlini M; Wanner D; Nitsch RM
    Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic Amyloid PET: Relationships to
    Raman F; Fang YD; Grandhi S; Murchison CF; Kennedy RE; Morris JC; Massoumzadeh P; Benzinger T; Roberson ED; McConathy J
    J Nucl Med; 2022 Feb; 63(2):287-293. PubMed ID: 34049986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.